Director/PDMR Shareholding

RNS Number : 6125B

GlaxoSmithKline PLC

18 April 2012

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 18 April 2012 of an increase in their notional interests in Ordinary Shares at a price of 1420 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $45.47 per ADS following the notional re-investment of the dividend paid to shareholders on 12 April 2012.

	Ordinary Shares	ADSs
Sir Andrew Witty	19,276.728
Dr M M Slaoui		5,763.192
Mr S Dingemans	3,717.248
Mr S M Bicknell	2,014.250
Mrs D P Connelly		2,869.501
Mr M Dunoyer	2,482.552
Mr E J Gray	4,180.417
Mr S A Hussain	5,297.088
Mr W C Louv		1,678.711
Dr D Pulman		2,501.300
Mr D S Redfern	2,571.532
Ms C Thomas	3,740.225
Mr P C Thomson	284.435
Mr D E Troy		3,202.482
Dr P J T Vallance	3,468.230
Ms E Walmsley	2,521.782
Mr C Weber	846.106
Mrs V A Whyte	284.435

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

18 April 2012

 

END

 

 

RDSZVLFFLZFLBBF